FDADecember 8, 2017device

Remel Shigella sonnei Phase 1 & 2 Agglutinating Serum, Ref R30164201 ZH01. Product Usage: Suitable for the use in slide agglutination tests to identify Shigella cultures presumptively for epidemiological and diagnostic purposes.

Official recall recorded by the U.S. Food & Drug Administration.

The hazard

The serum may fail to agglutinate within the specified minimum reaction time.

What to do

FDA enforcement status: Terminated

Brands named

remel

UPCs

50560805009592

Recall history

Other federal recalls tied to the same brand — a factual pattern, straight from the source data.

Own something like this?

AllClear screens your whole list against every CPSC, FDA, USDA and NHTSA recall — and tells you the day a new one names something you own.

Start free — 200 items, no card →